Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityNo recent work listed

Wei Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3024-380X; OpenAlex author ID A5002817911. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 3 papers

Papers 3

  1. Recent development of gene therapy for pancreatic cancer using non-viral nanovectors. First author DOI 10.1039/d1bm00748c↗
  2. Correction: Recent development of gene therapy for pancreatic cancer using non-viral nanovectors. First author DOI 10.1039/d1bm90082j↗
  3. Case Report: Effectiveness of Targeted Treatment in a Patient With Pancreatic Cancer Harboring PALB2 Germline Mutation and KRAS Somatic Mutation. Co-author DOI 10.3389/fmed.2021.746637↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xintao Shuai · 2 shared papers, 2021 · strength 0.28
  2. Peng Zhao · 2 shared papers, 2021 · strength 0.26
  3. Yu Liu · 1 shared paper, 2021 · strength 0.14
  4. Yu Liu · 1 shared paper, 2021 · strength 0.14
  5. Zhao Meng Peng · 1 shared paper, 2021 · strength 0.14
  6. Aibin Zhang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.